Cullinan Therapeutics Inc (CGEM)

Nov 04, 2025

Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail

Nov 04, 2025

Nov 04, 2025

Will Cullinan Therapeutics Inc. stock maintain dividend yieldJuly 2025 Setups & Entry Point Confirmation Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Cullinan Therapeutics Inc. stock trend forecast2025 Winners & Losers & Daily Growth Stock Investment Tips - newser.com

Nov 04, 2025

Nov 04, 2025

Using data filters to optimize entry into Cullinan Therapeutics Inc.July 2025 Chart Watch & Daily Market Momentum Tracking - newser.com

Nov 04, 2025

Nov 04, 2025

How Cullinan Therapeutics Inc. stock trades during market volatilityJuly 2025 Technicals & Entry Point Strategy Guides - newser.com

Nov 04, 2025

Nov 04, 2025

Can Cullinan Therapeutics Inc. stock attract ESG capital inflowsTrade Ideas & Detailed Earnings Play Alerts - newser.com

Nov 04, 2025

Nov 04, 2025

Is Cullinan Therapeutics Inc. stock a good choice for value investorsWeekly Market Report & High Accuracy Investment Signals - newser.com

Nov 04, 2025

Nov 04, 2025

Will Cullinan Therapeutics Inc. stock recover after recent dropJuly 2025 Update & Daily Entry Point Alerts - newser.com

Nov 04, 2025

Nov 03, 2025

Cullinan Therapeutics (CGEM) Reveals Promising Phase 1 Data for CLN-049 in AML and MDS - GuruFocus

Nov 03, 2025

Nov 03, 2025

Cullinan Therapeutics Inc. stock daily chart insights2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Can Cullinan Therapeutics Inc. stock beat market expectations this quarterJuly 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025

Nov 03, 2025

Cullinan Management Unveils Promising CLN-049 Clinical Data - TipRanks

Nov 03, 2025

Nov 03, 2025

Heatmap analysis for Cullinan Therapeutics Inc. and competitorsMarket Weekly Review & Verified Entry Point Signals - newser.com

Nov 03, 2025

Nov 03, 2025

Cullinan Therapeutics Presents New Data on CLN-049 at ASH Meeting - TradingView

Nov 03, 2025

Nov 03, 2025

Cullinan (NASDAQ: CGEM) announces 69% ORR for CLN-049 in r/r AML; Phase 1 shows manageable safety - Stock Titan

Nov 03, 2025

Nov 03, 2025

Visual analytics tools that track Cullinan Therapeutics Inc. performanceWeekly Volume Report & Weekly Chart Analysis and Guides - newser.com

Nov 03, 2025

Nov 03, 2025

Cullinan Therapeutics Inc. stock outlook for YEARJuly 2025 Movers & High Conviction Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Is Cullinan Therapeutics Inc. reversing from oversold territory2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

What machine learning models say about Cullinan Therapeutics Inc.2025 Top Decliners & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

Will Cullinan Therapeutics Inc. rebound enough to break evenWeekly Earnings Recap & Safe Entry Momentum Tips - newser.com

Nov 03, 2025

Nov 03, 2025

What makes Cullinan Therapeutics Inc. stock attractive to growth fundsQuarterly Profit Report & AI Driven Price Forecasts - newser.com

Nov 03, 2025

Nov 03, 2025

Backtesting results for Cullinan Therapeutics Inc. trading strategies2025 Volume Leaders & Real-Time Volume Analysis - newser.com

Nov 03, 2025

Nov 03, 2025

Why retail investors pile into Cullinan Therapeutics Inc. stockProduct Launch & Free Reliable Trade Execution Plans - newser.com

Nov 03, 2025

Nov 03, 2025

Will Cullinan Therapeutics Inc. stock gain from government policiesEarnings Overview Summary & Reliable Price Breakout Alerts - newser.com

Nov 03, 2025

Nov 01, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 13.5% After Insider Buying Activity - MarketBeat

Nov 01, 2025

Nov 01, 2025

Will Cullinan Therapeutics Inc. stock return to pre crisis levelsQuarterly Earnings Report & Verified Trade Idea Suggestions - newser.com

Nov 01, 2025

Nov 01, 2025

What momentum indicators show for Cullinan Therapeutics Inc. stockJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com

Nov 01, 2025

Oct 31, 2025

Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Lynx1 Capital Management Lp Purchases 165,667 Shares - MarketBeat

Oct 31, 2025